Mannatech, Inc. — FY2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021; comparison is FY2020. The supplied filing text does not provide standalone fourth-quarter results. Mannatech sells nutrition, skin care, and wellness products through network marketing in 24 markets, with cross-border e-commerce in China.
Financial performance
| Metric | FY2021 | FY2020 |
|---|---|---|
| Net sales | $159.8 million | $151.4 million |
| Gross profit / margin | $125.6 million / 78.6% | $115.9 million / 76.5% |
| Operating income / margin | $9.0 million / 5.7% | $4.5 million / 3.0% |
| Net income | $9.8 million | $6.3 million |
| Diluted EPS | $4.71 | $2.77 |
| Operating cash flow | $10.8 million | $6.0 million |
- Sales rose 5.5% reported, or 3.1% on a constant-dollar basis; favorable currency translation added $3.7 million. Product sales increased 3.3%, while pack sales and associate fees grew 90.5% to $8.0 million.
- Gross margin improved 2.1 percentage points, attributed to foreign exchange, selected price increases, and supply-chain improvements. Operating expenses increased 4.6%, slower than sales.
- Foreign markets generated 78.1% of sales. Asia/Pacific sales rose 6.1%; Americas rose 4.2%; EMEA rose 6.3%.
- Active associate and preferred-customer positions declined to approximately 163,000 from 183,000. Orders processed fell 2.3%, while average order value increased to $190 from $183.
- Five named product lines contributed 49.8% of sales, down from 53.9%. Ambrotose Life sales fell to $28.8 million from $36.1 million.
Cash, liquidity, and obligations
- Cash, cash equivalents, and restricted cash totaled $25.6 million at year-end, down from $27.5 million; currency movements reduced cash by $2.7 million. Working capital was $12.7 million, up from $10.5 million.
- Operating cash flow of $10.8 million funded $0.7 million of investing outflows and $9.3 million of financing outflows. Financing included $4.3 million of dividends and $5.1 million of share repurchases.
- The balance sheet reported $0.2 million of current notes payable and $0.1 million of finance lease liabilities. Operating lease liabilities were $5.8 million. Management said operating cash flow and existing liquidity should fund expected operations for the next 12 months; the company reported no off-balance-sheet arrangements.
- Foreign bank-account cash was $22.6 million, including a concentration of net assets in South Korea. A $4.8 million minimum-purchase commitment for aloe-based raw materials extends through 2022.
Material developments, outlook, and risks
- Tax presentation to verify: The income-statement summary labels $0.950 million as an income tax provision, but the reported pretax income of $8.892 million and net income of $9.842 million imply a $0.950 million benefit. The tax note also reports a $0.950 million benefit and a negative 10.7% effective tax rate.
- Other operating costs include a $0.6 million charge for the most probable outcome of an ongoing Korean customs valuation audit. The company is also seeking a ruling on whether certain intercompany currency netting required advance reporting under Korean foreign-exchange rules; a penalty is possible if reporting was required.
- A Chinese product-liability case seeking approximately $286,600 resulted in a favorable December 2021 judgment, but the plaintiff appealed in March 2022. The filing says the outcome and any liability cannot yet be estimated. Management said no legal reserve was necessary at year-end.
- The FTC sent the company a 2021 notice concerning money-making opportunities, endorsements, and testimonials. The filing says receipt was not a determination of wrongdoing; penalties could follow only through further proceedings.
- COVID-19-related supply constraints, freight and logistics challenges, event disruptions, and uncertain consumer demand could weigh on sales and liquidity. The company also flagged currency volatility and noted it does not hedge foreign-exchange exposure. Russia’s invasion of Ukraine and resulting sanctions could affect European operations and shipping costs.
- No specific financial guidance was provided. Management described liquidity as adequate for expected operations, subject to maintaining or improving sales relative to operating costs.
- BDO USA, LLP issued an unqualified opinion on the consolidated financial statements. Management concluded internal control over financial reporting was effective; the auditor was not engaged to audit internal controls.
Key investor verification points
- Reconcile the $950,000 tax benefit/provision labeling against the audited statements and tax note.
- Track active network positions, order trends, and reliance on high-contribution products, particularly Ambrotose Life.
- Monitor the Korean customs audit and foreign-exchange reporting determination, including any additional exposure beyond the recorded $0.6 million.
- Follow the appeal in the Chinese product-liability case and developments in the FTC notice process.
- Assess cash generation against dividends, repurchases, the 2022 supplier commitment, and concentrated foreign cash balances.